World report on fertility treatments reveals high use of intracytoplasmic sperm injection
(European Society of Human Reproduction and Embryology) The editor-in-chief of one of the world's leading reproductive medicine journals, Human Reproduction, has attacked the rising use of intracytoplasmic sperm injection (ICSI) for the treatment of infertility, following publication of the latest world report on assisted reproductive technologies; he brands it as 'ineffective and costly care.'
Ejaculatory duct obstruction is a well-defined, potentially correctable cause of male infertility. It is diagnosed infrequently and is found in only up to 5% of infertile men (1). Male infertility due to ejaculatory duct obstruction is often secondary to azoospermia or, rarely, severe impairment of semen parameters even if some spermatozoa are present in the ejaculate. Because spermatogenesis is still normal in most of these men, surgical sperm retrieval for assisted reproduction with intracytoplasmic sperm injection is feasible and often is suggested as the first line of infertility management.
Condition: Infertility, Female Interventions: Drug: Growth Hormones Somatropin Recombinant; Drug: Placebo saline solution Sponsors: ClinAmygate; National Research Center, Egypt Not yet recruiting
AbstractThe purpose of this study was to compare the clinical outcome of testicular spermatozoon versus ejaculated spermatozoon in the treatment of infertile males with high sperm DNA damage, referred as sperm DNA fragmentation index (DFI), that attending intracytoplasmic sperm injection (ICSI) programme in terms of clinical pregnancy, births delivered as the primary and pregnancy loss and embryo fertilisation as the secondary outcome. A total of 102 males fulfilling the inclusion criteria were enrolled in the present study. Of the 102 males, 61 infertile males underwent testicular spermatozoon combined with ICSI while the...
Background.Infertility is common after HCT predominantly as a result of the chemoradiotherapy used in conditioning. Patients are increasingly encouraged to store gametes, tissue or embryos before transplant for use after their potentially sterilising treatment. Furthermore, some patients do retain or recover fertility and conceive naturally.Methods:We sent questionnaires to 602 EBMT centers requesting retrospective details of number of pregnancies following either allogeneic or autologous HCT, use of artificial reproductive techniques (ART) and pregnancy outcome for all patients treated between 1995-2015.Results:47 centers...
Lab Chip, 2018, Accepted Manuscript DOI: 10.1039/C8LC01075G, PaperLindong Weng, Gloria Lee, Jie Liu, Ravi Kapur, Thomas Toth, Mehmet Toner Human infertility can be treated using assisted reproductive technology (ART) such as intracytoplasmic sperm injection (ICSI). But current ART techniques suffer from multiple cumbersome processes requiring technically skilled personnel. Microfluidics... The content of this RSS Feed (c) The Royal Society of Chemistry
Abstract Non-obstructive azoospermia (NOA) is the most severe clinical diagnosis in cases of male infertility. Although in some cases of NOA spermatozoa can be retrieved by microdissection testicular sperm extraction (micro-TESE) to fertilise eggs through intracytoplasmic sperm injection (ICSI), there remains a lack of potential biomarkers for non-invasive diagnosis before micro-TESE surgery. To determine predictive biomarkers for successful sperm retrieval before micro-TESE, the aim of this study was to explore whether microRNAs (miRNAs) were differentially expressed in testicular tissues in NOA patients in whom ...
This article is protected by copyright. All rights reserved.
Condition: Infertility Intervention: Sponsor: Aljazeera Hospital Not yet recruiting